If you plan on attending the Indian Society for Clinical Research 2025 Conference in Mumbai this year, connect with MMS leaders onsite, including Arshi Ghousia, Associate Manager of Regulatory and Medical Writing, and Priya Roy, Ph.D., Team Lead in Clinical Trial Disclosure!
Our experts are ready to discuss how MMS delivers innovative, data-driven solutions in regulatory, medical writing, clinical trial disclosure, and more data CRO solutions to support your success in the ever-evolving drug development landscape.
Ghousia will give a thought-provoking presentation, titled “Role of Medical Writing in Patient-Centric Documents that Support the Success of Clinical Trials in India.” This is expected to occur during a pre-conference workshop on January 31st between 2-5pm.
Schedule A Meeting Now
Please share your details to schedule a meeting with MMS representatives at this event, and let’s explore a future where accuracy, innovation, and unparalleled expertise drive your success.
Suggested For You
webinar
December 4th, 2025
Writing with Quality Control in Mind: A Cross-functional Approach
webinar
June 26th, 2025
De-Risking Development with Specialized Data Strategies: From Trial Design to Submission
perspectives
November 4th, 2025
4 Key Takeaways from the EMA - Health Canada Joint Review Process and Evaluation of Its Efficiency
perspectives
October 28th, 2025
New Updates on Clinical Trial Transparency and Regulatory Requirements: A Comprehensive Overview
webinar
October 21st, 2025
A Practical Guide to Expedited Regulatory Pathways
perspectives
October 21st, 2025
Shaping Clinical Development Through Writing: Francesca’s Journey at MMS
news
October 16th, 2025
MMS Named Finalist in the Fierce Life Sciences Innovation Awards for KerusCloud® Clinical Trial Simulation Platform
perspectives
October 14th, 2025
CRO Partnerships and Biotech Agility: How Smaller Sponsors Gain Speed in Clinical Development
perspectives
October 7th, 2025
From Academia to Building Medical Writing Partnerships: Jessica Murdock’s MMS Story
news
October 2nd, 2025
MMS Announces Its Role in Supporting Gates Ventures and the GNPC to Deliver One of the World's Largest Proteomic Datasets for Neurodegenerative Diseases
perspectives
September 30th, 2025
Ready by Design: Endpoints, Feasibility, and Scenario Testing
news
September 24th, 2025
MMS Named Finalist in Citeline’s 2025 Scrip Awards for Best Contract Research Organization (CRO) – Specialist Providers